ErbB-targeted CAR T-cell immunotherapy of cancer: a strategy to maximize the window of therapeutic opportunity.
Dr John Maher, Senior Lecturer in Immunology, NIHR Biomedical Research Centre at Guy¹s and St Thomas¹ NHS Foundation, Trust and King¹s College London, Research Oncology, Division of Cancer Studies, Guy's Hospital campus, St Thomas St, London, United Kingdom
Current status of minimally invasive diagnosis and staging of lung malignancies
Dr Jorge Pascual, MD, Assistant Professor, Mayo Clinic College of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Florida, USA
Overcoming Mechanisms of Therapeutic Resistance in Advanced Castration Resistant Prostate Cancer
Dr Natasha Kyprianou, James F. Hardymon Chair in Urology Research, Professor of Urology, Molecular Biochemistry, Pathology and Toxicology, Combs, Rm 306, University of Kentucky College of Medicine, Lexington, KY, US
Breast Cancer, Chemo-resistance and ErbB receptors
Professor Zhixiang Wang, PhD, Department of Medical Genetics, Signal Transduction Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding cancer screening, prevention and treatment. Presenters will include Clinicians, Academics and members of the Pharmaceutical industry and we encourage presentations from the wide spectrum of cancer research, development and healthcare professionals.
- Organization: Euroscicon
